Interplay between chromatin-modifying enzymes controls colon cancer progression through Wnt signaling

Human Molecular Genetics

Volumn 23, Issue 8, 2014, Pages 2120-2131

  Chevillard briet, Martine ^a,b   Quaranta, Muriel ^a,b   Grézy, Aude ^a,b   Mattera, Lise ^a,b   Courilleau, Céline ^a,b   Philippe, Magali ^a,c   Mercier, Pascale ^a,c   Corpet, Denis ^d   Lough, John ^e   Ueda, Takeshi ^f   Fukunaga, Rikiro ^g   Trouche, Didier ^a,b   Escaffit, Fabrice ^a,b  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b Université de Toulouse Paul Sabatier   (France)

^c INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^d UNIVERSITÉ DE TOULOUSE   (France)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f HIROSHIMA UNIVERSITY   (Japan)

^g OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; HISTONE ACETYLTRANSFERASE; P400 PROTEIN; PROTEIN; TIP60 HISTONE ACETYLTRANSFERASE; UNCLASSIFIED DRUG;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CELL TRANSFORMATION; CELL VIABILITY; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; GENOME ANALYSIS; HETEROZYGOSITY; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WNT SIGNALING PATHWAY;

ACETYLATION; ANIMALS; BETA CATENIN; BLOTTING, WESTERN; CELLS, CULTURED; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; COLONIC NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; HISTONE ACETYLTRANSFERASES; HISTONES; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PRECANCEROUS CONDITIONS; PROTEIN PROCESSING, POST-TRANSLATIONAL; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANS-ACTIVATORS; WNT PROTEINS;

EID: 84897902588     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt604     Document Type: Article

References (51)

1. Aran, D. and Hellman, A. (2013) DNA methylation of transcriptional enhancers and cancer predisposition. Cell, 154, 11-13.
2. Bojang, P. Jr and Ramos, K.S. (2013) The promise and failures of epigenetic therapies for cancer treatment. Cancer Treat. Rev., 40, 153-169.
3. Skene, P.J. and Henikoff, S. (2013) Histone variants in pluripotency and disease. Development, 140, 2513-2524.
4. Fullgrabe, J., Kavanagh, E. and Joseph, B. (2011) Histone onco-modifications. Oncogene, 30, 3391-3403.
5. Gorrini, C., Squatrito, M., Luise, C., Syed, N., Perna, D., Wark, L., Martinato, F., Sardella, D., Verrecchia, A., Bennett, S. et al. (2007) Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response. Nature, 448, 1063-1067.
6. Mattera, L., Escaffit, F., Pillaire, M.J., Selves, J., Tyteca, S., Hoffmann, J.S., Gourraud, P.A., Chevillard-Briet, M., Cazaux, C. and Trouche, D. (2009) The p400/Tip60 ratio is critical for colorectal cancer cell proliferation through DNA damage response pathways. Oncogene, 28, 1506-1517.
7. Kaidi, A. and Jackson, S.P. (2013) KAT5 tyrosine phosphorylation couples chromatin sensing to ATM signalling. Nature, 498, 70-74.
8. Sun, Y., Jiang, X., Chen, S., Fernandes, N. and Price, B.D. (2005) A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Proc. Natl. Acad. Sci. USA, 102, 13182-13187.
9. Tang, Y., Luo, J., Zhang, W. and Gu, W. (2006) Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol. Cell, 24, 827-839.
10. Dar, A., Shibata, E. and Dutta, A. (2013) Deubiquitination of Tip60 by USP7 determines the activity of the p53-dependent apoptotic pathway. Mol. Cell. Biol., 33, 3309-3320.
11. Sykes, S.M., Mellert, H.S., Holbert, M.A., Li, K., Marmorstein, R., Lane, W.S. and McMahon, S.B. (2006) Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol. Cell, 24, 841-851.
12. Ikura, T., Ogryzko, V.V., Grigoriev, M., Groisman, R., Wang, J., Horikoshi, M., Scully, R., Qin, J. and Nakatani, Y. (2000) Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell, 102, 463-473.
13. Gevry, N., Chan, H.M., Laflamme, L., Livingston, D.M. and Gaudreau, L. (2007) p21 transcription is regulated by differential localization of histone H2A.Z. Genes Dev., 21, 1869-1881.
14. Tyteca, S., Vandromme, M., Legube, G., Chevillard-Briet, M. and Trouche, D. (2006) Tip60 and p400 are both required for UV-induced apoptosis but play antagonistic roles in cell cycle progression. EMBO J., 25, 1680-1689.
15. Park, J.H., Sun, X.J. and Roeder, R.G. (2010) The SANT domain of p400 ATPase represses acetyltransferase activity and coactivator function of TIP60 in basal p21 gene expression. Mol. Cell. Biol., 30, 2750-2761.
16. Fearon, E.R. (2011) Molecular genetics of colorectal cancer. Annu. Rev. Pathol., 6, 479-507.
17. Cheng, L. and Lai, M.D. (2003) Aberrant crypt foci as microscopic precursors of colorectal cancer. World J. Gastroenterol., 9, 2642-2649.
18. Lopez-Ceron, M. and Pellise, M. (2012) Biology and diagnosis of aberrant crypt foci. Colorectal Dis., 14, e157-e164.
19. Parnaud, G., Tache, S., Peiffer, G. and Corpet, D.E. (1999) Polyethylene-glycol suppresses colon cancer and causes dose-dependent regression of azoxymethane-induced aberrant crypt foci in rats. Cancer Res., 59, 5143-5147.
20. Pierre, F.H., Santarelli, R.L., Allam, O., Tache, S., Naud, N., Gueraud, F. and Corpet, D.E. (2010) Freeze-dried ham promotes azoxymethane-induced mucin-depleted foci and aberrant crypt foci in rat colon. Nutr. Cancer, 62, 567-573.
21. Boivin, G.P., Washington, K., Yang, K., Ward, J.M., Pretlow, T.P., Russell, R., Besselsen, D.G., Godfrey, V.L., Doetschman, T., Dove, W.F. et al. (2003) Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology, 124, 762-777.
22. Guda, K., Upender, M.B., Belinsky, G., Flynn, C., Nakanishi, M., Marino, J.N., Ried, T. and Rosenberg, D.W. (2004) Carcinogen-induced colon tumors in mice are chromosomally stable and are characterized by low-level microsatellite instability. Oncogene, 23, 3813-3821.
23. Takahashi, M.and Wakabayashi, K. (2004) Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci., 95, 475-480.
24. Elyada, E., Pribluda, A., Goldstein, R.E., Morgenstern, Y., Brachya, G., Cojocaru, G., Snir-Alkalay, I., Burstain, I., Haffner-Krausz, R., Jung, S. et al. (2011) CKIalpha ablation highlights a critical role for p53 in invasiveness control. Nature, 470, 409-413.
25. Mattera, L., Courilleau, C., Legube, G., Ueda, T., Fukunaga, R., Chevillard-Briet, M., Canitrot, Y., Escaffit, F. and Trouche, D. (2010) The E1A-associated p400 protein modulates cell fate decisions by the regulation of ROS homeostasis. PLoS Genetics, 6, e1000983.
26. Hu, Y., Fisher, J.B., Koprowski, S., McAllister, D., Kim, M.S. and Lough, J. (2009) Homozygous disruption of the Tip60 gene causes early embryonic lethality. Dev. Dyn., 238, 2912-2921.
27. Ueda, T., Watanabe-Fukunaga, R., Ogawa, H., Fukuyama, H., Higashi, Y., Nagata, S. and Fukunaga, R. (2007) Critical role of the p400/mDomino chromatin-remodeling ATPase in embryonic hematopoiesis. Genes Cells, 12, 581-592.
28. De Robertis, M., Massi, E., Poeta, M.L., Carotti, S., Morini, S., Cecchetelli, L., Signori, E. and Fazio, V.M. (2011) The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies. J. Carcinog., 10, 9.
29. Lu, Q., Jiang, B., Lin, C. and Shan, T. (2008) Dark Aberrant Crypt Foci with activated Wnt pathway are related to tumorigenesis in the colon of AOM-treated rat. J. Exp. Clin. Cancer Res., 27, 26.
30. Proffitt, K.D., Madan, B., Ke, Z., Pendharkar, V., Ding, L., Lee, M.A., Hannoush, R.N. and Virshup, D.M. (2012) Pharmacological inhibition of the Wnt acyltransferase PORCN prevents growth of WNT-driven mammary cancer. Cancer Res., 73, 502-507.
31. Proffitt, K.D. and Virshup, D.M. (2012) Precise regulation of porcupine activity is required for physiological Wnt signaling. J. Biol. Chem., 287, 34167-34178.
32. Handeli, S. and Simon, J.A. (2008) A small-molecule inhibitor of Tcf/beta-catenin signaling down-regulates PPARgamma and PPARdelta activities. Mol. Cancer Ther., 7, 521-529.
33. Iida, J., Dorchak, J., Lehman, J.R., Clancy, R., Luo, C., Chen, Y., Somiari, S., Ellsworth, R.E., Hu, H., Mural, R.J. et al. (2012) FH535 inhibited migration and growth of breast cancer cells. PLoS ONE, 7, e44418.
34. Beaulieu, J.F. and Menard, D. (2012) Isolation, characterization, and culture of normal human intestinal crypt and villus cells. Methods Mol. Biol., 806, 157-173.
35. Levy, L., Wei, Y., Labalette, C., Wu, Y., Renard, C.A., Buendia, M.A. and Neuveut, C. (2004) Acetylation of beta-catenin by p300 regulates beta-catenin-Tcf4 interaction. Mol. Cell. Biol., 24, 3404-3414.
36. Wolf, D., Rodova, M., Miska, E.A., Calvet, J.P. and Kouzarides, T. (2002) Acetylation of beta-catenin by CREB-binding protein (CBP). J. Biol. Chem., 277, 25562-25567.
37. Ge, X., Jin, Q., Zhang, F., Yan, T. and Zhai, Q. (2009) PCAF acetylates {beta}-catenin and improves its stability. Mol. Biol. Cell, 20, 419-427.
38. Kolligs, F.T., Nieman, M.T., Winer, I., Hu, G., Van Mater, D., Feng, Y., Smith, I.M., Wu, R., Zhai, Y., Cho, K.R. et al. (2002) ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation. Cancer Cell, 1, 145-155.
39. Mologni, L., Dekhil, H., Ceccon, M., Purgante, S., Lan, C., Cleris, L., Magistroni, V., Formelli, F. and Gambacorti-Passerini, C.B. (2010) Colorectal tumors are effectively eradicated by combined inhibition of {beta}-catenin, KRAS, and the oncogenic transcription factor ITF2. Cancer Res., 70, 7253-7263.
40. Bottomly, D., Kyler, S.L., McWeeney, S.K. and Yochum, G.S. (2010) Identification of {beta}-catenin binding regions in colon cancer cells using ChIP-Seq. Nucleic Acids Res., 38, 5735-5745.
41. Ishitani, T., Kishida, S., Hyodo-Miura, J., Ueno, N., Yasuda, J., Waterman, M., Shibuya, H., Moon, R.T., Ninomiya-Tsuji, J. and Matsumoto, K. (2003) The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling. Mol. Cell. Biol., 23, 131-139.
42. Baek, S.H., Ohgi, K.A., Rose, D.W., Koo, E.H., Glass, C.K. and Rosenfeld, M.G. (2002) Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell, 110, 55-67.
43. Feng, Y., Lee, N. and Fearon, E.R. (2003) TIP49 regulates beta-catenin-mediated neoplastic transformation and T-cell factor target gene induction via effects on chromatin remodeling. Cancer Res., 63, 8726-8734.
44. Chan, H.M., Narita, M., Lowe, S.W. and Livingston, D.M. (2005) The p400 E1A-associated protein is a novel component of the p53 → p21 senescence pathway. Genes Dev., 19, 196-201.
45. Zheng, H., Seit-Nebi, A., Han, X., Aslanian, A., Tat, J., Liao, R., Yates, J.R. 3rd. and Sun, P. (2013) A Posttranslational modification cascade involving p38, Tip60, and PRAK mediates oncogene-induced senescence. Mol. Cell, 50, 699-710.
46. Berns, K., Hijmans, E.M., Mullenders, J., Brummelkamp, T.R., Velds, A., Heimerikx, M., Kerkhoven, R.M., Madiredjo, M., Nijkamp, W., Weigelt, B. et al. (2004) A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature, 428, 431-437.
47. Legube, G., Linares, L.K., Tyteca, S., Caron, C., Scheffner, M., Chevillard-Briet, M. and Trouche, D. (2004) Role of the histone acetyl transferase Tip60 in the p53 pathway. J. Biol. Chem., 279, 44825-44833.
48. Lleonart, M., Vidal, F., Gallardo, D., Diaz-Fuertes, M., Rojo, F., Cuatrecasas, M., Lopez-Vicente, L., Kondoh, H., Blanco, C., Carnero, A. et al. (2006) New p53 related genes in human tumors: significant downregulation in colon and lung carcinomas. Oncol. Rep., 16, 603-608.
49. Holland, J.D., Klaus, A., Garratt, A.N. and Birchmeier, W. (2013) Wnt signaling in stem and cancer stem cells. Curr. Opin. Cell Biol., 25, 254-264.
50. Clevers, H. and Nusse, R. (2012) Wnt/beta-catenin signaling and disease. Cell, 149, 1192-1205.
51. Tabas-Madrid, D., Nogales-Cadenas, R. and Pascual-Montano, A. (2012) GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics. Nucleic Acids Res., 40, W478-W483.